Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 5.00
-0.13 (-2.53%)
Aug 21, 2026, 4:08 PM HKT
Jiangsu Recbio Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1.87 | 12.73 | - | - | - | - |
Other Revenue | -2.54 | - | - | 30.38 | 5.33 | 6.2 |
| -0.67 | 12.73 | - | 30.38 | 5.33 | 6.2 | |
Revenue Growth | - | - | - | 470.46% | -14.10% | 325.17% |
Cost of Revenue | 3.49 | 3.49 | 11.06 | 8.04 | - | - |
Gross Profit | -4.16 | 9.24 | -11.06 | 22.34 | 5.33 | 6.2 |
Selling, General & Admin | 87.65 | 92.95 | 111.67 | 152.24 | 163.96 | 146.51 |
Research & Development | 383.98 | 520.7 | 476.12 | 487.85 | 716.44 | 472.95 |
Operating Expenses | 471.62 | 613.65 | 587.79 | 640.09 | 880.4 | 619.46 |
Operating Income | -475.78 | -604.41 | -598.85 | -617.75 | -875.08 | -613.26 |
Interest Expense | -20.99 | -23.96 | -18.9 | -13.57 | -3.53 | -56.31 |
Interest & Investment Income | 2.8 | 2.8 | 21.38 | 45.58 | 23.98 | 10.36 |
Currency Exchange Gain (Loss) | 0.3 | 0.3 | 8.97 | 17.5 | 115.06 | -8.49 |
Other Non Operating Income (Expenses) | 13.5 | 17.13 | 29.3 | -2.12 | 0.02 | -1.06 |
EBT Excluding Unusual Items | -480.15 | -608.12 | -558.1 | -570.36 | -739.55 | -668.76 |
Gain (Loss) on Sale of Investments | - | - | - | - | 3.56 | 11.22 |
Gain (Loss) on Sale of Assets | -0.11 | -0.11 | 0.06 | 6.61 | - | -0.02 |
Asset Writedown | - | - | -3.86 | -8.69 | - | - |
Pretax Income | -480.26 | -608.23 | -561.9 | -572.44 | -736 | -657.57 |
Income Tax Expense | 1.3 | 2.16 | - | - | - | - |
Earnings From Continuing Operations | -481.56 | -610.39 | -561.9 | -572.44 | -736 | -657.57 |
Minority Interest in Earnings | - | - | -0.49 | 0.49 | 13.29 | 0.01 |
Net Income | -481.56 | -610.39 | -562.39 | -571.96 | -722.7 | -657.56 |
Preferred Dividends & Other Adjustments | - | - | -4.93 | - | - | - |
Net Income to Common | -481.56 | -610.39 | -557.46 | -571.96 | -722.7 | -657.56 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 603 | 531 | 479 | 481 | 474 | 421 |
Shares Outstanding (Diluted) | 603 | 531 | 479 | 481 | 474 | 421 |
Shares Change | 26.18% | 11.01% | -0.50% | 1.42% | 12.52% | 36.60% |
EPS (Basic) | -0.80 | -1.15 | -1.16 | -1.19 | -1.52 | -1.56 |
EPS (Diluted) | -0.80 | -1.15 | -1.16 | -1.19 | -1.52 | -1.56 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -601.5 | -636.66 | -850.11 | -876.27 | -710.79 |
Free Cash Flow Per Share | - | -1.13 | -1.33 | -1.77 | -1.85 | -1.69 |
Gross Margin | - | 72.61% | - | 73.54% | 100.00% | 100.00% |
Operating Margin | - | -4749.39% | - | -2033.60% | -16433.33% | -9892.89% |
Profit Margin | - | -4796.40% | - | -1882.86% | -13571.89% | -10607.53% |
Free Cash Flow Margin | - | -4726.54% | - | -2798.55% | -16455.78% | -11466.17% |
EBITDA | -366.07 | -492.16 | -528.06 | -569.87 | -847.67 | -598.36 |
D&A For EBITDA | 109.71 | 112.25 | 70.79 | 47.88 | 27.41 | 14.9 |
EBIT | -475.78 | -604.41 | -598.85 | -617.75 | -875.08 | -613.26 |